ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,032Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 337

$403K Total Retail Price of All Prescriptions

Rank: 104 out of 337

373 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 373 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 373 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 9,169 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 460 454 1 11
OMEPRAZOLE 433 405 2 4
FUROSEMIDE 385 371 3 8
AMLODIPINE BESYLATE 323 299 4 3
LEVOTHYROXINE SODIUM 316 283 5 5
SIMVASTATIN 316 289 5 1
ATORVASTATIN CALCIUM 313 297 7 7
METOPROLOL TARTRATE 296 289 8 6
ENALAPRIL MALEATE 278 262 9 37
CITALOPRAM HBR 255 247 10 17
SERTRALINE HCL 248 210 11 18
LISINOPRIL 219 191 12 2
TRAZODONE HCL 180 161 13 16
ATENOLOL 132 120 14 10
DONEPEZIL HCL 129 127 15 22
TRAMADOL HCL 126 123 16 32
DIOVAN 118 103 17 26
LOSARTAN POTASSIUM 108 104 18 15
PREDNISONE 98 91 19 40
PRAVASTATIN SODIUM 95 95 20 14
LOVASTATIN 94 92 21 24
CIPROFLOXACIN HCL 91 83 22 71
NAMENDA 88 85 23 35
ALENDRONATE SODIUM 86 68 24 19
ZOLPIDEM TARTRATE 85 79 25 23
MELOXICAM 85 79 25 54
METFORMIN HCL 84 69 27 12
BUPROPION HCL SR 82 50 28 154
GLYBURIDE-METFORMIN HCL 80 68 R 29 99
FENOFIBRATE 79 61 30 48
SPIRIVA 77 74 31 43
AMITRIPTYLINE HCL 73 41 R 32 75
GABAPENTIN 72 67 33 20
QUETIAPINE FUMARATE 72 63 33 61
HYDROCHLOROTHIAZIDE 66 61 35 9
LIPITOR 66 58 35 33
MIRTAZAPINE 65 65 37 27
CELEBREX 62 55 38 116
ALLOPURINOL 61 55 39 28
TRICOR 61 61 39 134
KLOR-CON M20 60 58 41 65
LEVOFLOXACIN 59 56 42 93
METOPROLOL SUCCINATE 59 56 42 21
CYMBALTA 59 48 42 59
TAMSULOSIN HCL 57 49 45 25
HYDROCODONE-ACETAMINOPHEN 56 53 S3 46 13
CRESTOR 55 41 47 29
ISOSORBIDE MONONITRATE ER 52 44 48 70
PANTOPRAZOLE SODIUM 52 41 48 36
RISPERIDONE 51 50 50 72
LEVOXYL 51 50 50 90
CYCLOBENZAPRINE HCL 50 49 R 52 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.